BGF invested in Intrapharm in August 2014 and supported the company's acquisition of three specialist pharma companies: Peckforton Pharmaceuticals, Alvedon, Aquamax. Following a period of sustained growth, with revenues increasing from £4m p.a. at the point of BGF’s investment to £12m in November 2015, the business was acquired by German pharmaceutical company RIEMSER Pharma GmbH. BGF exited its minority equity stake in the business, with all shareholders realising a strong return.
Aug 2014 – Nov 2015
Total BGF investment
Sign-up to BGF investment alerts